The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Lifshitz & Miller Law Firm Announces Investigation of Emeritus Corporation, Nu Skin Enterprises, Inc., The Medicines Company, Thoratec Corporation and TriQuint Semiconductor, Inc.

Wednesday, February 26, 2014

Lifshitz & Miller Law Firm Announces Investigation of Emeritus Corporation, Nu Skin Enterprises, Inc., The Medicines Company, Thoratec Corporation and TriQuint Semiconductor, Inc.

10:50 EST Wednesday, February 26, 2014

NEW YORK, Feb. 26, 2014 /PRNewswire/ --

Emeritus Corporation

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Emeritus Corporation ("Emeritus") (ESC) to Brookdale Senior Living Inc. for 0.95 shares of Brookdale common stock or transaction value totaling $2.8 billion, with the inclusion of $1.4 billion of Emeritus mortgage debt.

Lifshitz & Miller's investigation is focused on whether the Emeritus directors are acting in shareholders' best interest.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Nu Skin Enterprises, Inc.

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the District of Utah, alleging that Nu Skin Enterprises, Inc. ("Nu Skin") (NUS) issued false and misleading statements to investors between July 10, 2013 through January 16, 2014 by failing to disclose that the Company's operations in the People's Republic of China ("PRC") resulted in pyramid selling schemes in violation of PRC law.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

The Medicines Company

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the District of New Jersey, alleging that The Medicines Company ("Medicines") (MDCO) issued false and misleading statements to investors between February 20, 2013 and February 12, 2014, inclusive by failing to disclose that the Company's clinical trials for Cangrelor were unethically and inappropriately administered.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Thoratec Corporation

Lifshitz & Miller  announces that a class action was filed in the United States District Court for the Northern District of California, alleging that Thoratec Corporation ("Thoratec") (THOR) issued false and misleading statements to investors between April 29, 2010 and November 27, 2013, inclusive by failing to disclose that Company's HeartMate II Left Ventricular Assist Device had significant risk of pump thrombosis causing numerous fatalities.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

TriQuint Semiconductor, Inc.

Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of TriQuint Semiconductor, Inc. ("TriQuint") (TQNT) to RF Micro Devices, Inc. in a stock transaction with an implied price of $9.73 for each TriQuint share.

Lifshitz & Miller's investigation is focused on whether the proposed deal provides adequate value to TriQuint shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Lifshitz & Miller is a New York based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.  For more information about the firm, please visit our website at www.jlclasslaw.com.

ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.Lifshitz & MillerPhone:   516-493-9780 Facsimile: 516-280-7376Email: info@jlclasslaw.com

SOURCE Lifshitz & Miller Law Firm

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections